LIFESTANCE HEALTH GROUP INC (LFST) Stock Analyst Ratings
NASDAQ:LFST • US53228F1012
7.03 USD
+0.11 (+1.59%)
At close: Feb 13, 2026
6.92 USD
-0.11 (-1.56%)
After Hours: 2/13/2026, 8:21:37 PM
ChartMill assigns a Buy % Consensus number of 82% to LFST. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 8.95. This target is 27.36% above the current price.
- LFST was analyzed by 17 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about LFST.
- In the previous month the buy percentage consensus was at a similar level.
- LFST was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-02 | BTIG | Maintains | Buy -> Buy |
| 2025-12-12 | BTIG | Maintains | Buy -> Buy |
| 2025-12-09 | Barclays | Initiate | Overweight |
| 2025-11-13 | BMO Capital | Initiate | Outperform |
| 2025-11-07 | UBS | Maintains | Buy -> Buy |
| 2025-11-06 | BTIG | Maintains | Buy -> Buy |
| 2025-08-08 | UBS | Maintains | Buy -> Buy |
| 2025-05-27 | UBS | Upgrade | Neutral -> Buy |
| 2025-04-08 | Keybanc | Initiate | Overweight |
| 2025-04-03 | Canaccord Genuity | Initiate | Buy |
| 2024-12-16 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2024-11-11 | Barclays | Maintains | Underweight -> Underweight |
| 2024-08-15 | UBS | Maintains | Neutral -> Neutral |
| 2024-08-09 | Barclays | Maintains | Underweight -> Underweight |
| 2024-04-22 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2024-03-06 | Jefferies | Maintains | Buy -> Buy |
| 2024-03-04 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-02-29 | Barclays | Maintains | Underweight -> Underweight |
| 2023-11-22 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-11-17 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-08-10 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-07-13 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-05-19 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-05-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-01-06 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2022-11-15 | Goldman Sachs | Maintains | Neutral |
| 2022-11-14 | Cowen & Co. | Maintains | Outperform |
| 2022-08-22 | Cowen & Co. | Maintains | Outperform |
| 2022-05-10 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-12-17 | Morgan Stanley | Maintains | Equal-Weight |
LIFESTANCE HEALTH GROUP INC / LFST FAQ
Can you provide the average price target for LIFESTANCE HEALTH GROUP INC stock?
17 analysts have analysed LFST and the average price target is 8.95 USD. This implies a price increase of 27.36% is expected in the next year compared to the current price of 7.03.
Can you provide the consensus rating for LIFESTANCE HEALTH GROUP INC stock?
The consensus rating for LIFESTANCE HEALTH GROUP INC (LFST) is 82.3529 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover LIFESTANCE HEALTH GROUP INC (LFST) stock?
The number of analysts covering LIFESTANCE HEALTH GROUP INC (LFST) is 17.